174 related articles for article (PubMed ID: 23202893)
1. Interferon-β1b increases Th2 response in neuromyelitis optica.
Nakajima H; Hosokawa T; Doi Y; Ikemoto T; Ishida S; Kimura F; Hanafusa T
Int J Mol Sci; 2012 Sep; 13(10):12213-23. PubMed ID: 23202893
[TBL] [Abstract][Full Text] [Related]
2. Association of Th1/Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Kubo S; Kabasawa C; Kobayashi M; Ohashi T; Uchiyama S
Eur Neurol; 2011; 66(2):91-7. PubMed ID: 21846991
[TBL] [Abstract][Full Text] [Related]
3. Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.
Uzawa A; Mori M; Hayakawa S; Masuda S; Nomura F; Kuwabara S
BMC Neurol; 2010 Nov; 10():113. PubMed ID: 21067621
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Karni A; Balashov K; Hancock WW; Bharanidharan P; Abraham M; Khoury SJ; Weiner HL
J Neuroimmunol; 2004 Jan; 146(1-2):189-98. PubMed ID: 14698862
[TBL] [Abstract][Full Text] [Related]
5. Poor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.
Wang KC; Lin KH; Lee TC; Lee CL; Chen SY; Chen SJ; Chin LT; Tsai CP
PLoS One; 2014; 9(6):e98192. PubMed ID: 24887452
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
7. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis.
Shimizu Y; Fujihara K; Kubo S; Takahashi T; Misu T; Nakashima I; Yokoyama K; Itoyama Y; Uchiyama S
Tohoku J Exp Med; 2011 Mar; 223(3):211-4. PubMed ID: 21403431
[TBL] [Abstract][Full Text] [Related]
9. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Hayakawa S; Masuda S; Kuwabara S
Eur J Neurol; 2010 May; 17(5):672-6. PubMed ID: 20039942
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta(1b) treatment in neuromyelitis optica.
Tanaka M; Tanaka K; Komori M
Eur Neurol; 2009; 62(3):167-70. PubMed ID: 19590215
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling.
Misu T; Onodera H; Fujihara K; Matsushima K; Yoshie O; Okita N; Takase S; Itoyama Y
J Neuroimmunol; 2001 Mar; 114(1-2):207-12. PubMed ID: 11240033
[TBL] [Abstract][Full Text] [Related]
12. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
Balashov KE; Rottman JB; Weiner HL; Hancock WW
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
[TBL] [Abstract][Full Text] [Related]
13. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
Kutukculer N; Azarsiz E; Aksu G; Karaca NE
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
[TBL] [Abstract][Full Text] [Related]
16. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
[TBL] [Abstract][Full Text] [Related]
17. [Chemokines and chemokine receptors in multiple sclerosis].
Misu T; Fujihara K; Itoyama Y
Nihon Rinsho; 2003 Aug; 61(8):1422-7. PubMed ID: 12962033
[TBL] [Abstract][Full Text] [Related]
18. Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Harmel J; Ringelstein M; Ingwersen J; Mathys C; Goebels N; Hartung HP; Jarius S; Aktas O
BMC Neurol; 2014 Dec; 14():247. PubMed ID: 25516429
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.
Yamamoto J; Adachi Y; Onoue Y; Adachi YS; Okabe Y; Itazawa T; Toyoda M; Seki T; Morohashi M; Matsushima K; Miyawaki T
J Leukoc Biol; 2000 Oct; 68(4):568-74. PubMed ID: 11037980
[TBL] [Abstract][Full Text] [Related]
20. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.
Warabi Y; Matsumoto Y; Hayashi H
J Neurol Sci; 2007 Jan; 252(1):57-61. PubMed ID: 17125797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
